Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Experimental investigation of heterodyne quantum key distribution in the S-band or L-band embedded in a commercial C-band DWDM system.

Kleis S, Steinmayer J, Derksen RH, Schaeffer CG.

Opt Express. 2019 Jun 10;27(12):16540-16549. doi: 10.1364/OE.27.016540.

PMID:
31252878
2.

Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births.

Kroese SJ, de Hair MJH, Limper M, Lely AT, van Laar JM, Derksen RHWM, Fritsch-Stork RDE.

J Immunol Res. 2017;2017:2810202. doi: 10.1155/2017/2810202. Epub 2017 Dec 17.

3.

The development of offspring from mothers with systemic lupus erythematosus. A systematic review.

Yousef Yengej FA, van Royen-Kerkhof A, Derksen RHWM, Fritsch-Stork RDE.

Autoimmun Rev. 2017 Jul;16(7):701-711. doi: 10.1016/j.autrev.2017.05.005. Epub 2017 May 4. Review.

4.

Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?

Otten HG, Brummelhuis WJ, Fritsch-Stork R, Leavis HL, Wisse BW, van Laar JM, Derksen RHWM.

Clin Exp Rheumatol. 2017 May-Jun;35(3):462-470. Epub 2017 Feb 24.

PMID:
28240588
5.

Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.

van den Hoogen LL, Fritsch-Stork RD, Versnel MA, Derksen RH, van Roon JA, Radstake TR.

Ann Rheum Dis. 2016 Dec;75(12):e81. doi: 10.1136/annrheumdis-2016-210485. Epub 2016 Sep 28. No abstract available.

PMID:
27689737
6.

Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.

Tsang-A-Sjoe MW, Nagelkerke SQ, Bultink IE, Geissler J, Tanck MW, Tacke CE, Ellis JA, Zenz W, Bijl M, Berden JH, de Leeuw K, Derksen RH, Kuijpers TW, Voskuyl AE.

Rheumatology (Oxford). 2016 May;55(5):939-48. doi: 10.1093/rheumatology/kev433. Epub 2016 Jan 8.

PMID:
26748351
7.

Delineating the deranged immune system in the antiphospholipid syndrome.

van den Hoogen LL, van Roon JA, Radstake TR, Fritsch-Stork RD, Derksen RH.

Autoimmun Rev. 2016 Jan;15(1):50-60. doi: 10.1016/j.autrev.2015.08.011. Epub 2015 Aug 28. Review.

PMID:
26318678
8.

The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study.

van Mierlo HC, de Witte L, Derksen RH, Otten HG; GROUP investigators.

NPJ Schizophr. 2015 May 6;1:15013. doi: 10.1038/npjschz.2015.13. eCollection 2015.

9.

Annexin A5 haplotypes in the antiphospholipid syndrome.

Hiddink L, de Laat B, Derksen RH, de Groot PG, van Heerde WL.

Thromb Res. 2015 Feb;135(2):417-9. doi: 10.1016/j.thromres.2014.12.004. Epub 2014 Dec 5. No abstract available.

PMID:
25511578
10.

Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.

Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M; Dutch Working Party on SLE.

Neth J Med. 2014 Nov;72(9):481-90.

11.

Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.

Luijten RK, Cuppen BV, Bijlsma JW, Derksen RH.

Lupus. 2014 Dec;23(14):1512-6. doi: 10.1177/0961203314543918. Epub 2014 Jul 30.

PMID:
25078055
12.

Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?

Pennings MT, De Groot PG, Meijers JC, Huisman A, Derksen RH, Urbanus RT.

Thromb Haemost. 2014 Oct;112(4):736-42. doi: 10.1160/TH14-02-0122. Epub 2014 Jul 10.

PMID:
25008787
13.

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).

Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24.

14.

Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus.

Van Avondt K, Fritsch-Stork R, Derksen RH, Meyaard L.

PLoS One. 2013 Oct 18;8(10):e78459. doi: 10.1371/journal.pone.0078459. eCollection 2013.

15.

The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science.

Luijten RK, Fritsch-Stork RD, Bijlsma JW, Derksen RH.

Autoimmun Rev. 2013 Mar;12(5):617-28. doi: 10.1016/j.autrev.2012.12.001. Epub 2012 Dec 8. Review.

PMID:
23232124
16.

Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.

Overman CL, Hartkamp A, Bossema ER, Bijl M, Godaert GL, Bijlsma JW, Derksen RH, Geenen R.

Lupus. 2012 Dec;21(14):1515-21. doi: 10.1177/0961203312459105. Epub 2012 Aug 30.

PMID:
22936125
17.

Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.

van Tellingen A, Voskuyl AE, Vervloet MG, Bijl M, de Sévaux RG, Berger SP, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Neth J Med. 2012 May;70(4):199-207. Review.

18.

Pathophysiology of thrombotic APS: where do we stand?

de Groot PG, Urbanus RT, Derksen RH.

Lupus. 2012 Jun;21(7):704-7. doi: 10.1177/0961203312438631. Review.

PMID:
22635207
19.

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.

Martens HA, Nienhuis HL, Gross S, van der Steege G, Brouwer E, Berden JH, de Sévaux RG, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Nolte IM, Kallenberg CG, Bijl M.

Lupus. 2012 Aug;21(9):959-68. doi: 10.1177/0961203312444495. Epub 2012 Apr 18.

PMID:
22513366
20.

Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.

Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH; Dutch Working Party on systemic lupus erythematosus.

Ann Rheum Dis. 2012 Jun;71(6):966-73. doi: 10.1136/annrheumdis-2011-200384. Epub 2011 Nov 29.

PMID:
22128082
21.

Induction of anti-β2 -glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes.

van Os GM, Meijers JC, Agar Ç, Seron MV, Marquart JA, Åkesson P, Urbanus RT, Derksen RH, Herwald H, Mörgelin M, D E Groot PG.

J Thromb Haemost. 2011 Dec;9(12):2447-56. doi: 10.1111/j.1538-7836.2011.04532.x.

22.

Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndrome.

Hartkamp A, Geenen R, Kruize AA, Bossema ER, Godaert GL, Bootsma H, Bijlsma JW, Derksen RH.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2):318-21. Epub 2011 Apr 19.

PMID:
21504661
23.

Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity.

Dienava-Verdoold I, Boon-Spijker MG, de Groot PG, Brinkman HJ, Voorberg J, Mertens K, Derksen RH, de Laat B.

J Thromb Haemost. 2011 Apr;9(4):738-47. doi: 10.1111/j.1538-7836.2011.04212.x.

24.

Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.

van der Goes MC, Bossema ER, Hartkamp A, Godaert GL, Jacobs JW, Kruize AA, Derksen RH, Bijlsma JW, Geenen R.

J Rheumatol. 2011 Feb;38(2):285-8. doi: 10.3899/jrheum.100572. Epub 2010 Dec 15.

PMID:
21159832
25.

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.

Romay-Penabad Z, Aguilar-Valenzuela R, Urbanus RT, Derksen RH, Pennings MT, Papalardo E, Shilagard T, Vargas G, Hwang Y, de Groot PG, Pierangeli SS.

Blood. 2011 Jan 27;117(4):1408-14. doi: 10.1182/blood-2010-07-299099. Epub 2010 Nov 30.

26.

An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies.

De Laat B, Derksen RH, Reber G, Musial J, Swadzba J, Bozic B, Cucnik S, Regnault V, Forastiero R, Woodhams BJ, De Groot PG.

J Thromb Haemost. 2011 Jan;9(1):149-53. doi: 10.1111/j.1538-7836.2010.04068.x.

27.

Variability of fatigue during the day in patients with primary Sjögren's syndrome, systemic lupus erythematosus, and rheumatoid arthritis.

van Oers ML, Bossema ER, Thoolen BJ, Hartkamp A, Dekkers JC, Godaert GL, Kruize AA, Derksen RH, Bijlsma JW, Geenen R.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5):715-21. Epub 2010 Oct 22.

PMID:
20863446
28.

Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.

Martens HA, Gross S, van der Steege G, Brouwer E, Berden JH, de Sevaux R, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Kallenberg CG, Bijl M.

J Rheumatol. 2010 Nov;37(11):2226-31. doi: 10.3899/jrheum.091468. Epub 2010 Aug 3.

PMID:
20682662
29.

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

Agar C, van Os GM, Mörgelin M, Sprenger RR, Marquart JA, Urbanus RT, Derksen RH, Meijers JC, de Groot PG.

Blood. 2010 Aug 26;116(8):1336-43. doi: 10.1182/blood-2009-12-260976. Epub 2010 May 12.

PMID:
20462962
30.

Towards evidence-based treatment of thrombotic antiphospholipid syndrome.

Derksen RH, de Groot PG.

Lupus. 2010 Apr;19(4):470-4. doi: 10.1177/0961203309361483. Review.

PMID:
20353990
31.

The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.

de Groot PG, Derksen RH, Urbanus RT.

Lupus. 2010 Apr;19(4):389-93. doi: 10.1177/0961203309360542. Review.

PMID:
20353975
32.

Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.

Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH.

Ann Rheum Dis. 2010 Jun;69(6):1144-7. doi: 10.1136/ard.2009.117036. Epub 2009 Oct 22.

PMID:
19854713
33.

Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men.

de Laat B, de Groot PG, Derksen RH, Urbanus RT, Mertens K, Rosendaal FR, Doggen CJ.

Blood. 2009 Oct 22;114(17):3656-61. doi: 10.1182/blood-2009-03-212910. Epub 2009 Aug 25.

PMID:
19706887
34.

Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE.

Fritsch-Stork RD, Leguit RJ, Derksen RH.

Nat Rev Rheumatol. 2009 May;5(5):283-7. doi: 10.1038/nrrheum.2009.49.

PMID:
19412195
35.

Comment on: Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells.

Westerweel PE, Derksen RH, Verhaar MC.

Rheumatology (Oxford). 2009 Apr;48(4):453; author reply 453-4. doi: 10.1093/rheumatology/ken494. Epub 2009 Jan 22. No abstract available.

PMID:
19164424
36.

Platelets and the antiphospholipid syndrome.

Urbanus RT, Derksen RH, de Groot PG.

Lupus. 2008 Oct;17(10):888-94. doi: 10.1177/0961203308096344. Review.

PMID:
18827053
37.

Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndrome.

de Groot PG, Derksen RH, de Laat B.

Semin Thromb Hemost. 2008 Jun;34(4):347-55. doi: 10.1055/s-0028-1085477. Epub 2008 Sep 23. Review.

PMID:
18814068
38.

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.

Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher MM, Tincani A, Kontopoulou-Griva I, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Piette JC, Espinosa G, Bucciarelli S, Pisoni CN, Bertolaccini ML, Boffa MC, Hughes GR; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).

Ann Rheum Dis. 2009 Sep;68(9):1428-32. doi: 10.1136/ard.2008.093179. Epub 2008 Sep 18.

PMID:
18801761
39.

Pregnancy, chimerism and lupus nephritis: a multi-centre study.

Kremer Hovinga IC, Koopmans M, Grootscholten C, van der Wal AM, Bijl M, Derksen RH, Voskuyl AE, de Heer E, Bruijn JA, Berden JH, Bajema IM; Dutch Working Party on Systemic Lupus Erythematosus.

Lupus. 2008 Jun;17(6):541-7. doi: 10.1177/0961203308089324.

PMID:
18539707
40.

New developments in lupus-associated antiphospholipid syndrome.

Lockshin MD, Derksen RH.

Lupus. 2008 May;17(5):443-6. doi: 10.1177/0961203308090032. Review.

PMID:
18490424
41.

Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.

Urbanus RT, Pennings MT, Derksen RH, de Groot PG.

J Thromb Haemost. 2008 Aug;6(8):1405-12. doi: 10.1111/j.1538-7836.2008.03021.x. Epub 2008 May 15.

42.

The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes.

Nilsson M, Wasylik S, Mörgelin M, Olin AI, Meijers JC, Derksen RH, de Groot PG, Herwald H.

Mol Microbiol. 2008 Feb;67(3):482-92. Epub 2007 Dec 18.

43.

Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis.

Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, van Houwelingen HC, Derksen RH, Berden JH.

Nephrol Dial Transplant. 2008 Jan;23(1):223-30. Epub 2007 Nov 2.

PMID:
17981886
44.

Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.

Urbanus RT, Derksen RH, de Groot PG.

Blood Rev. 2008 Mar;22(2):93-105. Epub 2007 Oct 25. Review.

PMID:
17964017
45.

Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.

Grootscholten C, Snoek FJ, Bijl M, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party of SLE.

J Rheumatol. 2007 Aug;34(8):1699-707. Epub 2007 Jul 15.

PMID:
17659757
46.

Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.

Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH.

Ann Rheum Dis. 2008 Jan;67(1):91-7. Epub 2007 Jun 1.

PMID:
17545193
47.

beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation.

Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot PG.

Blood. 2007 Sep 1;110(5):1483-91. Epub 2007 May 8.

PMID:
17488878
48.

Platelets express three different splice variants of ApoER2 that are all involved in signaling.

Pennings MT, Derksen RH, Urbanus RT, Tekelenburg WL, Hemrika W, de Groot PG.

J Thromb Haemost. 2007 Jul;5(7):1538-44. Epub 2007 Apr 27.

49.

Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.

Westerweel PE, Luyten RK, Koomans HA, Derksen RH, Verhaar MC.

Arthritis Rheum. 2007 May;56(5):1384-96. Review. No abstract available.

50.

Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Westerweel PE, Luijten RK, Hoefer IE, Koomans HA, Derksen RH, Verhaar MC.

Ann Rheum Dis. 2007 Jul;66(7):865-70. Epub 2007 Feb 28.

Supplemental Content

Loading ...
Support Center